{
    "2020-07-30": [
        [
            {
                "time": "",
                "original_text": "速读社丨罗氏IL-6R抗体新冠三期临床失败诺华PI3K抑制剂获欧盟批准",
                "features": {
                    "keywords": [
                        "罗氏",
                        "IL-6R抗体",
                        "新冠",
                        "三期临床",
                        "失败",
                        "诺华",
                        "PI3K抑制剂",
                        "欧盟批准"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "「医药速读社」IL-6R抗体新冠三期临床失败 4款创新药中国获批",
                "features": {
                    "keywords": [
                        "IL-6R抗体",
                        "新冠",
                        "三期临床",
                        "失败",
                        "创新药",
                        "中国获批"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业重点事项点评：第三批带量采购规则变化较少 市场预期逐步稳定",
                "features": {
                    "keywords": [
                        "医药行业",
                        "带量采购",
                        "规则变化",
                        "市场预期",
                        "稳定"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北向资金大额净卖出，白酒行业估值是否已到天花板",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净卖出",
                        "白酒行业",
                        "估值",
                        "天花板"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}